Clinical trial

Bromocriptine for Patients With Schizophrenia and Prediabetes

NCT03575000

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-01-01

PhasePHASE4

Study timeline

Study start (estimated)2026-01-01Date precision: day

Registry last updated2025-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

PreDiabetesunresolved

Interventions

BromocriptineDRUG · verified · RxNorm: bromocriptine

Sponsors & collaborators

VA Pittsburgh Healthcare Systemlead sponsor

Mapped research locations

PittsburghPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03575000 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.